Cardiovascular Disease
Showing NaN - NaN of 43
Cardiovascular Disease, Alcohol Use Disorder, HIV Risk Trial in New York (Navigation, compensation, and personalization)
Not yet recruiting
- Cardiovascular Disease
- +3 more
- Navigation, compensation, and personalization
-
New York, New YorkNYC H+H/Bellevue
Apr 13, 2023
Cardiovascular Disease, Myocardial Infarction, Stroke Trial (Evolocumab, Routine Lipid Management)
Recruiting
- Cardiovascular Disease
- +3 more
- Evolocumab
- Routine Lipid Management
-
Fairhope, Alabama
- +14 more
Dec 21, 2022
Patients With Heart Failure Using HeartLogic
Completed
- Heart Failure
- +5 more
- HeartLogic Sensors
-
Birmingham, Alabama
- +87 more
Oct 24, 2022
Sleep, Cardiovascular Disease, Obesity Trial in New York (Sleep Restriction)
Completed
- Sleep
- +2 more
- Sleep Restriction
-
New York, New YorkNew York Obesity Nutrition Research Center
May 11, 2022
Cardiovascular Disease, Acute Coronary Syndrome Trial in United States (Multifaceted Intervention with pharmacist and IVR)
Completed
- Cardiovascular Disease
- Acute Coronary Syndrome
- Multifaceted Intervention with pharmacist and IVR
-
Aurora, Colorado
- +14 more
Feb 8, 2022
Clinical Outcomes: An InteRnational Multicenter Registry
Completed
- Atherosclerosis
- +2 more
-
Los Angeles, California
- +19 more
Jan 12, 2022
Cardiovascular Disease Trial in New York (control group, Lifestyle management)
Completed
- Cardiovascular Disease
- control group
- Lifestyle management
-
New York, New YorkNYU Langone
Dec 7, 2021
Heart Failure, Anemia, Cardiovascular Disease Trial in Worldwide (Darbepoetin alfa, Placebo)
Completed
- Heart Failure
- +4 more
- Darbepoetin alfa
- Placebo
-
Birmingham, Alabama
- +753 more
Oct 31, 2021
Circulating Donor-Specific DNA in Organ Transplant Recipients
Completed
- Cardiovascular Disease
- +3 more
- Blood Draw of up to 10 ml
-
Little Rock, Arkansas
- +7 more
Mar 23, 2021
Cardiovascular Disease, Interventional Cardiology Trial in New York (Aspirin, Placebo, ticagrelor)
Completed
- Cardiovascular Disease
- Interventional Cardiology
- Aspirin
- +2 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Dec 23, 2020
Elevated Lipoprotein(a), Cardiovascular Disease Trial in Worldwide (ISIS 681257, Placebo)
Completed
- Elevated Lipoprotein(a)
- Cardiovascular Disease
- ISIS 681257
- Placebo
-
Cottonwood, Arizona
- +31 more
Oct 26, 2020
Osteoarthritis, Cardiovascular Disease Trial in New York (Metoprolol, Lisinopril, Atorvastatin)
Terminated
- Osteoarthritis
- Cardiovascular Disease
- Metoprolol
- +3 more
-
New York, New YorkNYU Hospital for Joint Diseases
Jul 20, 2020
Cardiovascular Disease Trial in Canada, Puerto Rico, United States (Methotrexate, Placebo)
Cardiovascular Disease Trial in Worldwide (Dalcetrapib, Placebo)
Terminated
- Cardiovascular Disease
- Dalcetrapib
- Placebo
-
Los Angeles, California
- +109 more
Mar 20, 2020
Hyperlipidemia, Hypercholesterolemia, Cardiovascular Disease Trial in United States
Completed
- Hyperlipidemia
- +16 more
-
Little Rock, Arkansas
- +13 more
Feb 27, 2020
Elevated Triglycerides, Diabetes, Cardiovascular Disease Trial in New York (Fructose + Glucose Beverage)
Completed
- Elevated Triglycerides
- +3 more
- Fructose + Glucose Beverage
-
New York, New York
- +1 more
Jun 14, 2019
Cardiovascular Disease, High Cardiovascular Risk, Obesity Trial in Worldwide (Lorcaserin HCl, Placebo)
Completed
- Cardiovascular Disease
- +4 more
- Lorcaserin hydrochloride
- Placebo
-
Alexander City, Alabama
- +498 more
Jun 27, 2019
Cardiovascular Disease, High Blood Pressure Trial in New York (Million Hearts ABCS 6 Months, Million Hearts ABCS 9 Months,
Completed
- Cardiovascular Disease
- High Blood Pressure
- Million Hearts ABCS 6 Months
- +15 more
-
New York, New YorkNew York University School of Medicine
May 17, 2019
Cardiovascular Disease Trial in Worldwide (bococizumab (PF-04950615), Placebo)
Terminated
- Cardiovascular Disease
- bococizumab (PF-04950615)
- Placebo
-
Athens, Alabama
- +1595 more
Apr 18, 2019
Platelet Activity in Vascular Surgery and Cardiovascular Events
Completed
- Cardiovascular Disease
- +2 more
-
New York, New YorkNYU Langone Medical Center and School of Medicine
Dec 4, 2018
Palliative Medicine, Cardiovascular Disease Trial in United States (discontinue statins)
Completed
- Palliative Medicine
- Cardiovascular Disease
- discontinue statins
-
Birmingham, Alabama
- +14 more
Aug 22, 2018
Cardiovascular Disease Trial in Worldwide (bococizumab (PF-04950615), Placebo)
Terminated
- Cardiovascular Disease
- bococizumab (PF-04950615)
- Placebo
-
Athens, Alabama
- +1745 more
Jun 14, 2018
Cardiovascular Disease Trial in Mexico, United States (Febuxostat, Allopurinol)
Completed
- Cardiovascular Disease
-
Decatur, Georgia
- +202 more
Jun 12, 2018
Cardiovascular Disease Trial in United States (EVARREST™, Topical hemostat, Standard of Care)
Completed
- Cardiovascular Disease
- EVARREST™
- +2 more
-
Indianapolis, Indiana
- +5 more
May 18, 2018